ArticleJournal of immunological methods2017

A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo.

Mohit K Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.